Intelsat Selected by Air Canada for Expanded Fleet Connectivity
5.9.2023 18:00:00 EEST | Business Wire | Press release
Air Canada and Intelsat, operator of one of the world’s largest integrated satellite and terrestrial networks and leading provider of in-flight connectivity (IFC), today announced an agreement for Intelsat to provide connectivity systems for nearly 100 additional aircraft across the airline’s fleet, including Intelsat’s new multi-orbit electronically steered array (ESA) antenna for aircraft in the airline’s regional jet fleet.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905161445/en/
Intelsat currently operates in-flight internet on 240 aircraft spanning Air Canada, Rouge and Air Canada Express. The new program includes IFC installations on three types of Air Canada aircraft. (Photo: Business Wire)
“Intelsat has been delivering reliable in-flight connectivity to Air Canada and its passengers for 14 years,” said Dave Bijur, Senior Vice President Commercial for Intelsat Commercial Aviation. “Air Canada’s leadership will continue for decades to come thanks to this investment in 2Ku connectivity for the 737 MAX fleet and the decision to install Intelsat’s innovative multi-orbit service across their regional jet operation.”
“The efforts and the commitment of Intelsat’s team and their service partners made the difference for us. We’re confident Intelsat provides proven technology, an extensible platform and network, and the right vision for the future of in-flight connectivity,” said Mark Nasr, Air Canada’s Executive Vice President, Marketing and Digital, and President of Aeroplan. “Through our Bell partnership, equipment installation schedule, and strong conviction around the importance of in-flight connectivity, we seek to offer our customers the best and most consistently available offering in the industry.”
Intelsat currently operates in-flight internet on 240 aircraft spanning Air Canada, Rouge and Air Canada Express. The new program includes IFC installations on three types of Air Canada aircraft:
- Boeing 737 MAX aircraft – the fleet of 40 aircraft will be equipped starting this year with Intelsat’s 2Ku IFC system.
- Embraer 175 and Mitsubishi CRJ-900 aircraft (currently installed with Intelsat’s air-to-ground system) – The 55 aircraft are currently flown by Air Canada’s Jazz regional partner and will be upgraded with Intelsat’s new ESA antenna starting in 2024.
Air Canada’s flag carrier and its regional partner Jazz together operate over 300 aircraft and they offer more Wi-Fi equipped flights than any other airline in Canada. The relationship with Intelsat will serve as a key enabler as Air Canada seeks to offer its customers the fastest and most consistently available Internet connectivity in the industry, throughout its global network.
Intelsat’s 2Ku solution is the industry’s leader due to its combination of a low-profile, fuselage-mounted antenna and its reliable on-wing performance. The smaller aircraft in the airline’s regional jet fleet will benefit from Intelsat’s new ESA which is less than three inches tall and interoperates on both Intelsat’s family of geo-stationary satellites and on OneWeb’s constellation of Low Earth Orbit (LEO) satellites. This strategy enables Air Canada to deliver the highest quality inflight internet experience available to airlines, wherever it flies.
About Intelsat
Intelsat’s worldwide team of professionals is focused on providing seamless and secure, satellite-based communications to government, NGO and commercial customers through the company’s next-generation global network and managed services. Bridging the digital divide by operating one of the world’s largest and most advanced satellite fleet and connectivity infrastructures, Intelsat enables people and their tools to speak over oceans, see across continents and listen through the skies to communicate, cooperate and coexist. Since its founding six decades ago, the company has been synonymous with satellite-industry “firsts” in service to its customers and the planet. Leaning on a legacy of innovation and focusing on addressing a new generation of challenges Intelsat team members now have their sights on the “next firsts” in space as they disrupt the field and lead in the digital transformation of the industry.
About Air Canada
Air Canada is Canada's largest airline, the country’s flag carrier and a founding member of Star Alliance, the world's most comprehensive air transportation network. Air Canada provides scheduled service directly to more than 180 airports in Canada, the United States and Internationally on six continents. It holds a Four-Star ranking from Skytrax. Air Canada’s Aeroplan program is Canada’s premier travel loyalty program, where members can earn or redeem points on the world’s largest airline partner network of 45 airlines, plus through an extensive range of merchandise, hotel and car rental rewards. Its freight division, Air Canada Cargo, provides air freight lift and connectivity to hundreds of destinations across six continents using Air Canada’s passenger and freighter aircraft. Air Canada aims to achieve an ambitious net zero emissions goal from all global operations by 2050. Air Canada shares are publicly traded on the TSX in Canada and the OCTQX in the U.S.
Follow Us on Social Media:
Twitter, LinkedIn, Facebook, Instagram, YouTube
# # #
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230905161445/en/
Contact information
Media Contact:
Melissa Longo - melissa.longo@intelsat.com; +1 240-308-1881
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom